349
Nautilus Biotechnology, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
187
FY23:
177
FY24:
133
FY25:
106
(positive)
Change from FY21 to FY25
millions USD
FY21:
49.2
FY22:
163
FY23:
129
FY24:
110
FY25:
85.1
Total assets
Change from FY21 to FY25
millions USD
FY21:
398
FY22:
350
FY23:
306
FY24:
243
FY25:
191
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.81
FY22:
6.79
FY23:
9.12
FY24:
7.63
FY25:
7.95
(negative)
Change from FY21 to FY25
millions USD
FY21:
29.1
FY22:
28.3
FY23:
31.1
FY24:
26.4
FY25:
26.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
364
FY22:
315
FY23:
265
FY24:
209
FY25:
157
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
398
FY22:
350
FY23:
306
FY24:
243
FY25:
191
All amounts in millions USD